Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer : A Randomized Controlled Trial

NCT07125924 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT07125924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07125924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer : A Randomized Controlled Trial
Lead sponsor
National Cancer Center, Korea
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 22, 2025
Completion date
December 31, 2027
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, radiation cystitis